Compare Keysight Technologies Inc (KEYS) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Keysight Technologies Inc vs Vir Biotechnology Inc. Common Stock — how do they compare? Keysight Technologies Inc trades at $326.31 (market cap $60.88B), while Vir Biotechnology Inc. Common Stock trades at $10.34 (market cap $1.76B). The key difference: Keysight Technologies Inc is far larger — about 34.6× Vir Biotechnology Inc. Common Stock's market cap, and Vir Biotechnology Inc. Common Stock is more actively traded (2,764,948 versus 1,470,178). Which is the better fit depends on your goals — on Pluang, investors hold Keysight Technologies Inc for 57 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.
| KEYS | VIR | |
|---|---|---|
Market Cap | $60.88B | $1.76B |
Volume | 1,470,178 | 2,764,948 |
Sector | Technology | Health |
52-Week High | $387.90 | $11.78 |
52-Week Low | $162.19 | $5.12 |
Typical Hold Time | 57 Days | 0 Days |
Enterprise Value | $61.02B | $1.32B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Keysight Technologies (KEYS) trades at $370.22, down 1.98% on the day, with a bullish technical outlook supported by moving averages and strong institutional sentiment. The company reported robust earnings beats in recent quarters, with Q2 2026 EPS of $3.07 exceeding expectations, and maintains solid profitability with a net income margin of 19.14%. Recent news highlights growth in AI infrastructure and 6G development, positioning KEYS for future expansion amid accelerating demand.
The investment outlook for KEYS is positive, driven by earnings momentum and strategic positioning in high-growth areas like AI and 6G. Key risks include elevated valuation multiples and potential supply constraints, but analyst consensus targets $421.29, suggesting ~14% upside from current levels based on strong fundamentals and institutional support.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Keysight Technologies Inc
Keysight Technologies is a leader in the field of testing and measurement, helping electronics OEMs and suppliers alike bring products to market to fit industry standards and specifications. Keysight specializes in the communications market, but also supplies into the government, automotive, industrial, and semiconductor manufacturing markets. Keysight's solutions include testing tools, analytical software, and services. The firm's stated objective is to reduce time to market and improve efficiency at its more than 30,000 customers.
Read more on KEYS →About Vir Biotechnology Inc. Common Stock
Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.
Read more on VIR →
